Global Pathogen mNGS Detection Market Growth (Status and Outlook) 2024-2030
The global Pathogen mNGS Detection market size is projected to grow from US$ 99.8 million in 2023 to US$ 157.6 million in 2030; it is expected to grow at a CAGR of 6.7% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Pathogen mNGS Detection Industry Forecast” looks at past sales and reviews total world Pathogen mNGS Detection sales in 2023, providing a comprehensive analysis by region and market sector of projected Pathogen mNGS Detection sales for 2024 through 2030. With Pathogen mNGS Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pathogen mNGS Detection industry.
This Insight Report provides a comprehensive analysis of the global Pathogen mNGS Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pathogen mNGS Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pathogen mNGS Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pathogen mNGS Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pathogen mNGS Detection.
United States market for Pathogen mNGS Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pathogen mNGS Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pathogen mNGS Detection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pathogen mNGS Detection players cover WillingMed Technology, Hangzhou Matridx Biotechnology, Yuguo Biotechnology(Beijing), BGI Genomics and Guangzhou Kingmed Diagnostics Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pathogen mNGS Detection market by product type, application, key players and key regions and countries.
Segmentation by type
Technology Platform
Testing Service
Segmentation by application
Hospital
Testing Facility
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
WillingMed Technology
Hangzhou Matridx Biotechnology
Yuguo Biotechnology(Beijing)
BGI Genomics
Guangzhou Kingmed Diagnostics Group
Guangzhou Weiyuan Gene Technology
Capitalbio
Beijing Golden Key Gene Technology
IngeniGen
Difei Medical Technology
Please note: The report will take approximately 2 business days to prepare and deliver.